MedDataX Logo

Bed Rest for Idiopathic Sudden Sensorineural Hearing Loss

NCT ID: NCT00416143

Last Updated: 2006-12-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE2/PHASE3

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-06-30

Study Completion Date

2008-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

sudden sensorineural hearing loss:

* idiopathic in most cases
* 5-20/100,000 new cases annually in the U.S
* no establishes pathogenesis
* treated with oral steroids in most cases
* \~50% improvement in hearing levels
* bed rest - acceptable treatment, not well investigated

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sudden Loss of Hearing

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Bed rest for idiopathic sudden sensorineural hearing loss

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

bed rest

Intervention Type PROCEDURE

prednisone - oral corticosteroid 1mg/kg/D for 1 week

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients with sudden sensorineural hearing loss

Exclusion Criteria

* age less than 16 years
* contraindication for oral steroid treatment
* prior steroid treatment for hearing loss
* pregnent women
Minimum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sheba Medical Center

OTHER_GOV

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Eldar Carmel, MD

Role: PRINCIPAL_INVESTIGATOR

Sheba Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sheba Medical Center

Tel Litwinsky, , Israel

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Israel

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Eldar Carmel, MD

Role: CONTACT

Phone: 972-3-5302442

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Eldar Carmel, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SHEBA-06-4065-EC-CTIL

Identifier Type: -

Identifier Source: org_study_id